JOANNA RUGGIERO: Open Payments
NPI 1750947495 · HAMBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,458 in 177 payments from 18 companies in 2025. Trend: 2023 $32 · 2024 $1,437 · 2025 $3,458
Food & beverage: $3,458
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $1,145 |
| Otsuka America Pharmaceutical, Inc. | 25 | $509 |
| Neurocrine BioSciences, Inc. | 11 | $273 |
| Teva Pharmaceuticals USA, Inc. | 16 | $224 |
| Lundbeck LLC | 19 | $218 |
| Alkermes, Inc. | 9 | $197 |
| Janssen Pharmaceuticals, Inc | 8 | $197 |
| Vanda Pharmaceuticals Inc. | 5 | $136 |
| Biogen, Inc. | 4 | $112 |
| Axsome Therapeutics, Inc. | 6 | $102 |
Products named: VRAYLAR, REXULTI, INGREZZA, ARISTADA, SPRAVATO, UZEDY, ZURZUVAE, Auvelity.
Industry payments across NY — which companies pay providers there.
